TY - JOUR
T1 - Obesity-related hypertension: Pathogenesis, cardiovascular risk, and treatment-a position paper of the the obesity society and the American society of hypertension
AU - Landsberg, L.
AU - Aronne, L.J.
AU - Beilin, Lawrence
AU - Burke, Valerie
AU - Igel, L.I.
AU - Lloyd-Jones, D.L.
AU - Sowers, J.R.
PY - 2013
Y1 - 2013
N2 - In light of the worldwide epidemic of obesity, and in recognition of hypertension as a major factor in the cardiovascular morbidity and mortality associated with obesity, The Obesity Society and The American Society of Hypertension agreed to jointly sponsor a position paper on obesity-related hypertension to be published jointly in the journals of each society. The purpose is to inform the members of both societies, as well as practicing clinicians, with a timely review of the association between obesity and high blood pressure, the risk that this association entails, and the options for rational, evidenced-based treatment. The position paper is divided into six sections plus a summary as follows: pathophysiology, epidemiology and cardiovascular risk, the metabolic syndrome, lifestyle management in prevention and treatment, pharmacologic treatment of hypertension in the obese, and the medical and surgical treatment of obesity in obese hypertensive patients.
AB - In light of the worldwide epidemic of obesity, and in recognition of hypertension as a major factor in the cardiovascular morbidity and mortality associated with obesity, The Obesity Society and The American Society of Hypertension agreed to jointly sponsor a position paper on obesity-related hypertension to be published jointly in the journals of each society. The purpose is to inform the members of both societies, as well as practicing clinicians, with a timely review of the association between obesity and high blood pressure, the risk that this association entails, and the options for rational, evidenced-based treatment. The position paper is divided into six sections plus a summary as follows: pathophysiology, epidemiology and cardiovascular risk, the metabolic syndrome, lifestyle management in prevention and treatment, pharmacologic treatment of hypertension in the obese, and the medical and surgical treatment of obesity in obese hypertensive patients.
U2 - 10.1002/oby.20181
DO - 10.1002/oby.20181
M3 - Article
C2 - 23401272
SN - 1930-7381
VL - 21
SP - 8
EP - 24
JO - Obesity
JF - Obesity
IS - 1
ER -